文献速递泌尿生殖腹部MR

基于MRI的影像组学预测前列腺癌前列腺外延伸:系统综述与Meta分析

MRI-based radiomics for prediction of extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
PubMed 文献 · Radiol Med · 2024-03-23

该系统综述与Meta分析纳入10项回顾性研究,评估MRI影像组学检测前列腺癌包膜外延伸的诊断性能,汇总敏感度0.77、特异度0.75,HSROC曲线下面积0.88,研究间存在显著异质性,作者认为影像组学诊断性能中等,与既往基于放射科医生主观经验的危险分层和模型相似,但需在前瞻性多中心研究中验证。

要点

  • MRI影像组学预测前列腺癌包膜外延伸的汇总敏感度0.77、特异度0.75,HSROC曲线下面积0.88。
  • 研究间异质性显著(敏感度和特异度I²均为83.5%),Meta回归未发现显著影响因素。
  • 作者指出影像组学诊断性能与既往基于放射科医生主观经验的危险分层和模型相似。

核心结论

  • MRI影像组学检测前列腺癌包膜外延伸呈现中等敏感度和特异度,诊断性能与既往主要基于放射科医生主观经验的危险分层和模型相似,但纳入研究均为回顾性,其性能需在前瞻性多中心研究中验证。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Cochrane Library、Web of Science和Google Scholar截至2023年7月的文献,按PRISMA声明报告,采用QUADAS-2工具和影像组学质量评分(RQS)评估纳入研究质量,共纳入10项研究,采用分层汇总受试者工作特征(HSROC)模型汇总估计值。

诊断标准与关键数值

  • 汇总敏感度0.77(95%CI 0.68-0.84,I²=83.5%),汇总特异度0.75(95%CI 0.67-0.82,I²=83.5%),HSROC曲线下面积0.88(95%CI 0.85-0.91);采用RQS评估时研究质量不高。

局限性

  • 采用RQS评估时纳入研究质量不高。
  • 研究间观察到显著异质性,敏感度和特异度I²均为83.5%。
  • Meta回归分析未发现任何显著的 contributing 因素。
  • 所有纳入研究均为回顾性,影像组学的性能需在前瞻性多中心研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: We to systematically evaluate the diagnostic performance of MRI radiomics in detecting extracapsular extension (EPE) of prostate cancer (PCa).

METHODS: A literature search of online databases of PubMed, EMBASE, Cochrane Library, Web of Science, and Google Scholar online scientific publication databases was performed to identify studies published up to July 2023. The summary estimates were pooled with the hierarchical summary receiver-operating characteristic (HSROC) model. This study was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement, the quality of included studies was assessed with the Quality Assessment of Diagnostic Accuracy Studies-2 tool (QUADAS-2) and the radiomics quality score (RQS). Meta-regression and subgroup analyses were performed to explore the impact of varying clinical settings.

RESULTS: A total of ten studies met the inclusion criteria. The pooled sensitivity and specificity were 0.77 (95% CI 0.68-0.84, I2 = 83.5%) and 0.75 (95% CI 0.67-0.82, I2 = 83.5%), respectively, with an area under the HSROC curve of 0.88 (95% CI 0.85-0.91). Study quality was not high while assessing with the RQS. Substantial heterogeneity was observed between studies; however, meta-regression analysis did not reveal any significant contributing factors.

CONCLUSIONS: MRI radiomics demonstrated moderate sensitivity and specificity, offering similar diagnostic performance with previous risk stratifications and models that primarily based on radiologists' subjective experience. However, all studies included were retrospective, thus the performance of radiomics needs to validate in prospective, multicenter studies.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Wen J, Liu W, Zhang Y, et al. MRI-based radiomics for prediction of extraprostatic extension of prostate cancer: a systematic review and meta-analysis. Radiol Med. 2024. PMID: 38520649. doi:10.1007/s11547-024-01810-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。